Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amgen Inc.
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Biotech
Market Cap: $146.15B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.36 | 0.99%
Avg Daily Range (30 D): $4.61 | 1.60%
Avg Daily Range (90 D): $3.63 | 1.25%
Institutional Daily Volume
Avg Daily Volume: 4.86M
Avg Daily Volume (30 D): 2.35M
Avg Daily Volume (90 D): 2.3M
Trade Size
Avg Trade Size (Sh.): 135
Avg Trade Size (Sh.) (30 D): 38
Avg Trade Size (Sh.) (90 D): 41
Institutional Trades
Total Inst.Trades: 112,694
Avg Inst. Trade: $6.14M
Avg Inst. Trade (30 D): $31.92M
Avg Inst. Trade (90 D): $32.23M
Avg Inst. Trade Volume: .05M
Avg Inst. Trades (Per Day): 20
Market Closing Trades
Avg Closing Trade: $63.89M
Avg Closing Trade (30 D): $163.91M
Avg Closing Trade (90 D): $170.5M
Avg Closing Volume: 386.12K
       
News
May 8, 2025 @ 3:00 PM
Amgen CEO Robert A. Bradway to Receive Honorary De...
Source: Globe Newswire
May 2, 2025 @ 7:57 PM
Amgen's Better Than Expected Q1 Earnings Take Back...
Source: Vandana Singh
May 2, 2025 @ 2:00 PM
Liver Cancer Treatment Market is expected to gener...
Source: Verified Market Research®
May 1, 2025 @ 12:30 PM
Beat the Nasdaq With This Cash-Gushing Dividend St...
Source: Dan Victor
Apr 26, 2025 @ 10:05 PM
4 Surefire Dividend Stocks to Buy in the Stock Mar...
Source: Prosper Junior Bakiny
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $3.22 $5.27
Diluted EPS $3.2 $5.22
Revenue $ $ 8.15B $ 8.5B
Gross Profit $ $ 5.18B $ 5.19B
Net Income / Loss $ $ 1.73B $ 2.83B
Operating Income / Loss $ $ 1.18B $ 2.05B
Cost of Revenue $ $ 2.97B $ 3.31B
Net Cash Flow $ $ -3163M $ -290M
PE Ratio